The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...

Injectable drugs like Ozempic and Mounjaro have transformed obesity treatment by mimicking gut hormones. But experts have ...

About 71% of U.S. adults are either overweight or obese, according to the Centers for Disease Control. That makes it easy to ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Since being approved by the FDA in 2021, the drugs have become so popular that, at one point, supply couldn't keep up with the demand.

Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...

Since being approved by the FDA in 2021, the drugs have become so popular that, at one point, supply couldn't keep up with the demand.

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.

A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but without diabetes, highlighting its superior effectiveness and cardiometabolic ...